financetom
Business
financetom
/
Business
/
Citigroup's Quarterly Results Beat Estimates Amid Trading, Investment Banking Gains
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Citigroup's Quarterly Results Beat Estimates Amid Trading, Investment Banking Gains
Jul 15, 2025 9:12 AM

11:39 AM EDT, 07/15/2025 (MT Newswires) -- Citigroup's ( C ) second-quarter results surpassed Wall Street's expectations, buoyed by trading gains and double-digit revenue growth in investment banking.

Earnings per share rose to $1.96 from $1.52 a year earlier and exceeded the consensus on FactSet for $1.61. Revenue grew 8% to $21.67 billion, above the Street's estimate of $20.96 billion.

Citigroup ( C ) shares were up 1.4% intraday Tuesday.

Citi's markets revenue jumped 16% to $5.88 billion, reflecting a 6% increase in equity trading to $1.61 billion. Fixed income market revenue surged 20%.

"Markets had its best second-quarter performance since 2020 with a record second quarter for equities," Chief Executive Jane Fraser said in a statement.

Banking revenue jumped 23% to $1.98 billion as investment banking grew 15% to $981 million amid gains in advisory and equity capital markets. Revenue in corporate lending soared 31%.

Citi joins JPMorgan Chase ( JPM ) and Wells Fargo ( WFC ) in reporting investment banking gains on Tuesday even as JPMorgan ( JPM ) Chief Executive Jamie Dimon said that economic risks remained.

Citi's wealth segment delivered a 20% jump in revenue to $2.17 billion, while US personal banking increased 6% to $5.12 billion.

UBS Securities said Tuesday that these results might attract more long-term shareholders.

"(Citi) is a well-known capital return potential story, but (the second-quarter) results imply that it could be more than this -- which could attract more long-term shareholders that had been reticent about owning shares," UBS analysts including Erika Najarian said in a note.

Price: 89.21, Change: +1.71, Percent Change: +1.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amneal Pharmaceuticals Insider Sold Shares Worth $491,382, According to a Recent SEC Filing
Amneal Pharmaceuticals Insider Sold Shares Worth $491,382, According to a Recent SEC Filing
Aug 16, 2024
04:22 PM EDT, 08/16/2024 (MT Newswires) -- Andrew S Boyer, Executive Vice President, on August 14, 2024, sold 62,711 shares in Amneal Pharmaceuticals ( AMRX ) for $491,382. Following the Form 4 filing with the SEC, Boyer has control over a total of 256,670 shares of the company, with 256,670 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1723128/000162828024037559/xslF345X03/wk-form4_1723839496.xml Price: 8.10, Change: +0.06,...
Warner Bros. Discovery Outlook Revised to Negative From Stable by S&P
Warner Bros. Discovery Outlook Revised to Negative From Stable by S&P
Aug 16, 2024
04:23 PM EDT, 08/16/2024 (MT Newswires) -- Warner Bros. Discovery's ( WBD ) outlook was revised to negative from stable due to elevated leverage and a weaker-than-expected operating performance in H1, S&P Global Ratings said Friday. The potential loss of National Basketball Association broadcast rights after the 2024-2025 season may impact Warner's linear television segment significantly and pressure its deleveraging...
Motorola Solutions Insider Sold Shares Worth $4,177,510, According to a Recent SEC Filing
Motorola Solutions Insider Sold Shares Worth $4,177,510, According to a Recent SEC Filing
Aug 16, 2024
04:23 PM EDT, 08/16/2024 (MT Newswires) -- Gregory Q Brown, Director, Chairman and CEO, on August 14, 2024, sold 10,000 shares in Motorola Solutions ( MSI ) for $4,177,510. Following the Form 4 filing with the SEC, Brown has control over a total of 416,897 shares of the company, with 49,065 shares held directly and 367,832 controlled indirectly. SEC Filing:...
Amneal Pharmaceuticals Insider Sold Shares Worth $775,000, According to a Recent SEC Filing
Amneal Pharmaceuticals Insider Sold Shares Worth $775,000, According to a Recent SEC Filing
Aug 16, 2024
04:23 PM EDT, 08/16/2024 (MT Newswires) -- Nikita Shah, Executive Vice President, on August 14, 2024, sold 100,000 shares in Amneal Pharmaceuticals ( AMRX ) for $775,000. Following the Form 4 filing with the SEC, Shah has control over a total of 291,666 shares of the company, with 291,666 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1723128/000162828024037557/xslF345X03/wk-form4_1723839453.xml Price: 8.10, Change: +0.06, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved